Pentraxin 3 might be better prognostic serum marker than IL-6, IL-10, and high-sensitivity C-reactive protein for major adverse cardiovascular events in patients with ST-elevation myocardial infarction after bare-metal stent implantation

OBJECTIVES: To assess the prognostic value of pentraxin 3 (PTX3) in patients with ST-elevation myocardial infarction (STEMI) after bare-metal stent (BMS) implantation. METHODS: In this prospective study, PTX3, interleukin (IL-6), IL-10, high-sensitivity c-reactive protein (hsCRP), and cardiac tropon...

Descripción completa

Detalles Bibliográficos
Autores principales: Ljuca, Farid, Hadžiefendić, Bahrudin, Jahić, Elmir, Tihić, Nijaz, Lukić, Saša
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Saudi Medical Journal 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6969622/
https://www.ncbi.nlm.nih.gov/pubmed/31828271
http://dx.doi.org/10.15537/smj.2019.12.24737

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6969622/
https://www.ncbi.nlm.nih.gov/pubmed/31828271
http://dx.doi.org/10.15537/smj.2019.12.24737

Ejemplares similares